Pharmacotherapy for Gastrointestinal and Hepatobiliary Disorders

Pharmacotherapy for Gastrointestinal and Hepatobiliary Disorders

From the case study and the symptoms given, it is evident that patient HL is suffering from a GI tract infection. The described symptoms are closely related to GI and hepatobiliary diseases. In certain cases, GI tract infections are self-limiting and disappear within 4 to 5 days when not treated (Staritz, 1999). Based on the medication therapy prescribed, the patient is being treated for GI disorder. Do you need any help for completing your assignment ? Contact us at eminencepapers.com. We endeavor to provide you with excellent service.

Rationale behind diagnosis

Hepatitis C is among the major causes of cirrhosis and raises the risks of health issues, especially when there is liver inflammation (Starr & Raines, 2011). Before going deeper into superseding, understanding the patient’s medical history is of great help. This is because medication influences a patient’s well-being.

Medicine prescriptions such as prednisone do not necessarily suppress the immune system; hence, there is a need to have a clear understanding of the reasons why a particular patient is on a certain medication. Understanding the medical history plays an important role in extending the verge of the symptoms occurrence as well as hepatitis. There is a likelihood that a certain patient is suffering from acute gastroenteritis in which the intestines appear to be irritated (Tablang & Katz, 2014). Acute gastroenteritis is caused by a virus.

According to the diagnosis and the prescription issued by the doctor, the same symptoms may hold for Acid-peptic diseases such as gastroesophageal reflux, peptic ulcers, and stress-related mucosal injury. According to such conditions, ulceration and mucosal erosions may arise due to causal factors such as bile, pepsin, and acid overact with gastrointestinal mucosa (Alpers, 1998). In the treatment of such infections, agents that suppress acidity and promote mucus defense may be used, as well as intragastric reducing agents.

References

Alpers, D. H., Kalloo, A. N., Kaplowitz, N., Owyang, C., & Powell, D. W. (2011). Textbook of gastroenterology. John Wiley & Sons.

Staritz, M. (1988). Pharmacology of the sphincter of Oddi. Endoscopy, 20(S 1), 171-174.

Diehl, D. L. (1999). Acupuncture for gastrointestinal and hepatobiliary disorders. The Journal of Alternative and Complementary Medicine, 5(1), 27-45.

ORDER A PLAGIARISM-FREE PAPER HERE

We’ll write everything from scratch

I hope everything is going well. This week, we will be working on the GI system. There is an assignment this week as you will be writing a paper on a scenario. I will say that there could be a few different diagnoses that this could be. However, I am looking more for signs that you choose a diagnosis and can support that based on your research. And as always, I will be looking for solid medication recommendations.

Pharmacotherapy for Gastrointestinal and Hepatobiliary Disorders

Please use the following case for your paper:

DC is a 46-year-old female who presents with a 24-hour history of RUQ pain. She states the pain started about 1 hour after a large dinner she had with her family. She had had nausea and for instance, vomiting before a presentation.